SEC Form 4 · accession 0001209191-18-055992
ChemoCentryx, Inc. · CCXI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Susan M Kanaya
Officer — EVP, CFO and Sec.
Period of report
Oct 20, 2018
Accepted (ET)
Oct 23, 2018 · 6:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001340652
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 20, 2018 | M | 33,333 | $0.00 | A | 71,468 | D | |
| Common StockF2 | Oct 20, 2018 | F | 17,940 | $11.41 | D | 53,528 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF3,F4 | — | Oct 20, 2018 | M | 33,333 | D | — | — | Common Stock | 33,333 | 33,334 | D |
Explanation of responses
- F1Shares were acquired upon vesting of restricted stock units awarded on October 24, 2016.
- F2Represents shares withheld upon vesting of restricted stock units to satisfy tax withholding obligation.
- F3Each restricted stock unit represents a contingent right to receive one share of CCXI common stock.
- F4The restricted stock units awarded on October 24, 2016, vest in three equal installments on October 20, 2017, October 20, 2018, and October 20, 2019, subject to the Reporting Person's continued employment or service relationship with the Issuer through each such vesting date. Vested shares will be delivered to the Reporting Person within thirty (30) days following the vesting date.